Nav1.2

SCN2A
Available structures
PDBHuman UniProt search: PDBe RCSB
Identifiers
Aliases SCN2A, BFIC3, BFIS3, BFNIS, EIEE11, HBA, HBSCI, HBSCII, NAC2, Na(v)1.2, Nav1.2, SCN2A1, SCN2A2, sodium voltage-gated channel alpha subunit 2
External IDs MGI: 98248 HomoloGene: 75001 GeneCards: SCN2A
Genetically Related Diseases
periodontitis[1]
Targeted by Drug
phenytoin[2]
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez

6326

110876

Ensembl

ENSG00000136531

ENSMUSG00000075318

UniProt

Q99250

n/a

RefSeq (mRNA)

NM_001040142
NM_001040143
NM_021007

NM_001099298

RefSeq (protein)

NP_001035232.1
NP_001035233.1
NP_066287.2

n/a

Location (UCSC) Chr 2: 165.24 – 165.39 Mb Chr 2: 65.62 – 65.77 Mb
PubMed search [3] [4]
Wikidata
View/Edit HumanView/Edit Mouse

Navα1.2, also known as the sodium channel, voltage-gated, type II, alpha subunit is a protein that in humans is encoded by the SCN2A gene.[5] Functional sodium channels contain an ion conductive alpha subunit and one or more regulatory beta subunits. Sodium channels which contain the Navα1.2 subunit are called Nav1.2 channels.

Function

Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four domains including 24 transmembrane segments and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is heterogeneously expressed in the brain, and mutations in this gene have been linked to several seizure disorders. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined.[5]

Clinical significance

Mutations in this gene have been implicated in cases of autism,[6] infantile spasms and bitemporal glucose hypometabolism.[7]

See also

References

  1. "Diseases that are genetically associated with SCN2A view/edit references on wikidata".
  2. "Drugs that physically interact with Sodium channel protein type 2 subunit alpha view/edit references on wikidata".
  3. "Human PubMed Reference:".
  4. "Mouse PubMed Reference:".
  5. 1 2 "Entrez Gene: SCN2A sodium channel, voltage-gated, type II, alpha subunit".
  6. Sanders SJ,, Stephan J.; Murtha MT; Gupta AR; Murdoch JR; Raubeson MJ; Willsey AJ; Ercan-Sencicek AG; et al. (2012). "De novo mutations revealed by whole-exome sequencing are strongly associated with autism". Nature. 485: 237–241. doi:10.1038/nature10945.
  7. Sundaram SK, Chugani HT, Tiwari VN, Huq AH (July 2013). "SCN2A Mutation Is Associated With Infantile Spasms and Bitemporal Glucose Hypometabolism". Pediatr. Neurol. 49 (1): 46–9. doi:10.1016/j.pediatrneurol.2013.03.002. PMID 23827426.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


This article is issued from Wikipedia - version of the 11/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.